Study design and subjects
DISEASES
This study is a single-blinded randomized, parallel-group trial with a 2 (intervention):1 (control) subject ratio. Subjects were adults free of diseases, aged 25 to 35 years, and with a BMI of 18.5 to 25 kg/m